P2-259: A feasibility study of adjuvant carboplatin (C) plus gemcitabine (G) in completely resected stage IB–III non–small–cell lung cancer (NSCLC)
2007 ◽
Vol 2
(8)
◽
pp. S675-S676
Atsushi Horiike
◽
Fumiyoshi Ohyanagi
◽
Yoshio Okano
◽
Yukitoshi Satoh
◽
Sakae Okumura
◽
...
2009 ◽
Vol 5
(1)
◽
pp. 19-22
◽
Hossein Borghaei
◽
Ranee Mehra
◽
George Simon
2017 ◽
Vol 12
(11)
◽
pp. S1983
M.K. Byun
◽
H.J. Park
◽
H.S. Park
◽
H. Jeung
◽
J.Y. Cho
◽
...
2017 ◽
Vol 25
(suppl_1)
◽
Xiao Li
◽
M Teng
◽
J Wang
2014 ◽
Vol 25
◽
pp. iv415
S. Wallerek
◽
J.B. Sorensen
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7019-7019
◽
H. Jie
◽
Z. Xiangru
◽
B. Han
◽
Y. Liu
◽
Q. Wang
◽
...
2016 ◽
Vol 46
(8)
◽
pp. 741-747
◽
Junichi Soh
◽
Norihito Okumura
◽
Masao Nakata
◽
Hiroshige Nakamura
◽
Minoru Fukuda
◽
...
2014 ◽
Vol 90
(5)
◽
pp. S2-S3
◽
N.K. Altorki
◽
M.E.R. O'brien
◽
W.E.E. Eberhardt
◽
F.C. Richardson
◽
J. Wang
◽
...
2006 ◽
Vol 7
(9)
◽
pp. 719-727
◽
Jean-Yves Douillard
◽
Rafael Rosell
◽
Mario De Lena
◽
Francesco Carpagnano
◽
Rodryg Ramlau
◽
...
2019 ◽
Vol 133
◽
pp. 75-82
◽
Xiao Li
◽
Chao Zhang
◽
Zewen Sun
◽
Fan Yang
◽
Rongxin Xiao
◽
...
2018 ◽
Vol 13
(10)
◽
pp. S845-S846
M. Nakata
◽
Y. Nojima
◽
K. Nanba
◽
S. Saisho
◽
K. Shimizu